Shoko Nishio

409 citations
9 papers · 362 indexed · h-index 7
Topics
Cancer-related Molecular Pathways (4 papers)Cell death mechanisms and regulation (3 papers)DNA Repair Mechanisms (2 papers)
Partner nations
Japan

In The Last Decade

Shoko Nishio

9 papers receiving 354 citations

Peers

Shoko Nishio
Comparison fields: 5 of 57
  • Molecular Biology 275
  • Oncology 104
  • Cell Biology 100
  • Physiology 53
  • Cancer Research 47
Replace Jing-Qing Luo with:
Jing-Qing Luo United States
Sandrine Palcy Canada
M. Cristina Castañeda‐Patlán Mexico
Maria Pia Gentileschi Italy
Stephanie H. Shirley United States
Carina Magnusson Australia
Fumihito Nakayama Japan
Christel Aperlo France
George A. Abou-Rjaily United States
Maria Sideridou Greece
Shoko Nishio relative to Jing-Qing Luo United States Jing-Qing Luo's profile →
Citations per field
00.5×
Jing-Qing Luo · 1×
Citations per year

Countries citing papers authored by Shoko Nishio

Since Specialization
Citations

This map shows the geographic impact of Shoko Nishio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoko Nishio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoko Nishio more than expected).

Fields of papers citing papers by Shoko Nishio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoko Nishio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoko Nishio. The network helps show where Shoko Nishio may publish in the future.

Co-authorship network of co-authors of Shoko Nishio

This figure shows the co-authorship network connecting the top 25 collaborators of Shoko Nishio. A scholar is included among the top collaborators of Shoko Nishio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoko Nishio. Shoko Nishio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 22
2 84
3 5
4 35
5 4
6
Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1.
28
7 27
8 111
9 46

About Shoko Nishio

Shoko Nishio is a scholar working on Cell Biology, Oncology and Biotechnology, having authored 9 papers that have together received 362 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Cell death mechanisms and regulation (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Cell Biology (100 citations), Molecular Biology (275 citations) and Oncology (104 citations). Shoko Nishio has collaborated with scholars based in Japan. Frequent co-authors include Kazuhiro Mizumoto, Hikaru Ueno, Naoki Maehara, Hiroshi Sakaue, Wataru Ogawa, Motoyoshi Sakaue, Masato Kasuga, Yoji Andrew Minamishima, Masao Tanaka and Masao Tanaka. Their work appears in journals such as Biochemical Journal, Clinical Cancer Research and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026